The application relates to an application of a
traditional Chinese medicine composition in a
drug for chronic obstructive
pulmonary disease, characterized in that the
traditional Chinese medicine composition comprises the following components in parts:
Magnolia officinalis 1-100 parts,
Strychnos ignatii 1-100 parts,
Toddalia asiatica 1-100 parts, Ephedra 1-100 parts, Amygdalus 1-100 parts, Notopterygium 1-100 parts,
Zingiber officinale 1-100 parts, Pogostemonis 1-100 parts, Perilla 1-100 parts, Atractylodes 1-100 parts, Poria cocos 1-160 parts,
Atractylodes macrocephala 1-120 parts,
Gypsum fibrosum 1-100 parts, Fructus Crataegi 1-100 parts, Fructus Junci 1-100 parts, Fructus Hordei 1-100 parts,
Lumbricus 1-100 parts, Radix et Rhizoma Veratri 1-100 parts, Herba Eupatorii Fortunei 1-100 parts,
Semen Lepidii 1-100 parts and
Semen Platycladi 1-100 parts.